Results

Total Results: 2,181 records

Showing results for "harms".

21. For pregnant women, or women recieving preconception care, with depression what are the comparative harms or benefits for both fetus/infant and the mother of continuing treatment with anti-depressants? | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/for-pregnant-women-or-women-recieving-preconception-care-with-depression-what-are-the-comparative-harms-or-benefits-for-both-fetusinfant-and-the-mother-of-continuing-treatment-with-anti-depressants
    November 01, 2017 - For pregnant women, or women recieving preconception care, with depression what are the comparative harms … For pregnant women, or women recieving preconception care, with depression what are the comparative harms … For pregnant women, or women recieving preconception care, with depression what are the comparative harms … mother, prevention of post-partum depression Describe any health-related risks, side effects, or harms … fetal harms- heart defects, preterm delivery, low apgar scores, admission to neonatal care unit, fetal

22. Communicating Harms and Benefits of Prescription Drugs to Healthcare Consumers (ppt file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/communicating_risk_hickam.ppt
    December 01, 2006 - Communicating Harms and Benefits of Prescription Drugs to Healthcare Consumers Communicating Harms … Healthcare Research and Quality Effective Health Care Program 1.bin Themes Drugs Consumers Harms … Recommendations for practice & research Morning Presentations Innovative Methods of Communicating Harms … Douglas Evans, PhD Communication of Harms and Benefits by Journalists and the Broader Media: What

23. Modeling to evaluate benefits and harms of new diagnostic tests compared to established diagnostic tests – uses and limitations (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/benefits-harms-modeling_research.pdf
    November 19, 2009 - Modeling to evaluate benefits and harms of new diagnostic tests compared to established diagnostic tests … Medical Tests—White Paper Series Decision-Analytic Modeling to Evaluate Benefits and Harms … Decision- analytic modelling to evaluate benefits and harms of medical tests: uses and limitations. … Decision-analytic modelling to evaluate benefits and harms of medical tests. … Technology, Hall I.T., Austria ii Decision-Analytic Modeling to Evaluate Benefits and Harms

24. Diagnosis and treatment of low back pain:Key questions:In patients with low back pain, what are the benefits and harms of identifying risk factors for chronicity and targeting treatment based on assessed… | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/diagnosis-and-treatment-of-low-back-painbr-key-questionsbr-olliin-patients-with-low-back-pain-what-are-the-benefits-and-harms-of-identifying-risk-factors-for-chronicity-and-targeting-treatment-based-on-assessed-riskliliin-pa
    November 01, 2017 - signs or symptoms suggesting a specific or serious underlying diagnosis, what are the benefits and harms … What are the comparative benefits and harms of different pharmacological therapies for non-radicular … What are the comparative benefits and harms of various interventional procedures for non-radicular low … What are the comparative benefits and harms of combinations of therapies (versus single therapies or … Describe any health-related risks, side effects, or harms that you are concerned about.

25. Diagnostic Errors in the Emergency Department: A Systematic Review | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/diagnostic-errors-emergency-updated/research
    August 01, 2023 - serious harms (permanent disability or death). … Preventability was determined by original study authors or differences in harms across groups. … The top 15 clinical conditions associated with serious misdiagnosis-related harms (accounting for 68% … [95% CI 66 to 71] of serious harms) were (1) stroke, (2) myocardial infarction, (3) aortic aneurysm … misdiagnosis-related harms (0.3%) could translate to more than 7 million errors, 2.5 million harms,

26. Therapies for Clinically Localized Prostate Cancer | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/prostate-cancer-therapies/report
    January 01, 2021 - treatments with duration ≥5 years for mortality and metastases and ≥1 year for quality of life and harms … Harms were greater with RP than AM and mixed between EBR plus AD versus AM. 3D-conformal EBR and AD plus … Active Surveillance may result in fewer harms than photodynamic therapy and laparoscopic RP may result … in more harms than robotic-assisted RP. … RP reduces mortality versus WW in clinically detected CLPC but causes more harms.

27. Executive Summary_Comparative Effectiveness Review No. 273_Treatment of Stages I-III Squamous Cell Anal Cancer: A Systematic Review (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-273-anal-cancer-executive-summary.pdf
    August 01, 2024 - , may increase hematologic toxicity, and may have no difference in late harms … (moderate SOE) and resulted in no difference in late harms (low SOE, Table A). … https://effectivehealthcare.ahrq.gov/products/cer-methods-guide 3 compare harms. … Low Late harms 1; RCT; n=682 No significant difference, imprecise estimates. … All harms are grade 3 or 4 unless specified otherwise.

28. 8 (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-harms_methods.pdf
    November 01, 2008 - . 2 However, assessing harms can be difficult. … Identifying Harms To Be Evaluated 2 CERs should always assess harms that are important to decisionmakers … when evaluating data on harms. … Terminology for reporting on harms Active surveillance of harms. … harms, whenever possible.

29. 8 (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/methodsguide_chou_assessing_harms_when_comparing.pdf
    November 01, 2008 - . 2 However, assessing harms can be difficult. … Identifying Harms To Be Evaluated 2 CERs should always assess harms that are important to decisionmakers … when evaluating data on harms. … Terminology for reporting on harms Active surveillance of harms. … harms, whenever possible.

30. Prevention, Diagnosis, and Management of Opioids, Opioid Misuse, and Opioid Use Disorder in Older Adults | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/opioids-older-adults/report
    January 01, 2022 - Opioid-related harms are increasing among older adults. … studies of factors associated with opioid-related outcomes and interventions to reduce opioid-related harms … (including screening tools), reduce opioid-related harms and disorders, and treat existing misuse or … to determine factors associated with and interventions for: (1) reducing opioid prescriptions where harms … The most-studied interventions were screening tools to predict opioid-related harms , but none of these

31. What is the efficacy and comparative effectiveness of pharmacological and nonpharmacological treatments for adults with schizophrenia What are the harms from pharmacological and nonpharmacological treatments for adults with… | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/what-is-the-efficacy-and-comparative-effectiveness-of-pharmacological-and-nonpharmacological-treatments-for-adults-with-schizophrenia-what-are-the-harms-from-pharmacological-and-nonpharmacological-treatments-for-adults-with-
    November 01, 2017 - effectiveness of pharmacological and nonpharmacological treatments for adults with schizophrenia What are the harms … effectiveness of pharmacological and nonpharmacological treatments for adults with schizophrenia What are the harms … the side effects of first line treatments What patient characteristics predict the effectiveness and harms … behaviors changes in the status of cooccurring disorders and the proportion of patients who experience key harms … protocols on bipolar disorder major depressive disorder and use of atypical antipsychotics for typical harms

32. What is the comparative effectiveness and harms of treatments for traumatic brain injury? Preliminary Key Questions 1. What is the comparative effectiveness of the treatments for TBI for grades I-IV? 2. For patients, what are the potential… | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/what-is-the-comparative-effectiveness-and-harms-of-treatments-for-traumatic-brain-injury-preliminary-key-questions-1-what-is-the-comparative-effectiveness-of-the-treatments-for-tbi-for-grades-i-iv-2-for-patients-what-are-the
    November 01, 2017 - SHARE: What is the comparative effectiveness and harms … What is the comparative effectiveness and harms of treatments for traumatic brain injury? … For patients, what are the potential harms of TBI treatment interventions? … quality of life, hospitalizations/ER visits Describe any health-related risks, side effects, or harms … Evidence regarding effectiveness and harms of treatments, or information regarding the lack of evidence

33. Interventional Treatments for Acute and Chronic Pain: Systematic Review | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/interventional-treatments-pain/research
    January 01, 2022 - Research is needed to determine the benefits and harms of other interventional procedures addressed in … populations, utilize sham controls, evaluate function as well as pain, include rigorous evaluation of harms … , evaluate longer-term outcomes, and evaluate how benefits and harms according to demographic, clinical … To evaluate the benefits and harms of selected interventional procedures for acute and chronic pain that … Review | Oct 29, 2021 Integrated and Comprehensive Pain Management Programs: Effectiveness and Harms

34. Management of Acute Diverticulitis | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/management-acute-diverticulitis
    January 01, 2019 - effectiveness/harms of oral or parenteral antibiotics for the treatment of diverticulitis compared to … Do the effectiveness/harms vary by patient characteristics or presentation of illness? … Do the benefits and harms vary by patient characteristics or presentation of illness? … Do the benefits and harms vary by patient characteristics or presentation/course of illness? … Do the benefits and harms vary by patient characteristics or presentation/course of illness?

35. AHRQ Slide Template 2009 (ppt file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/selecting-evidence.ppt
    January 01, 2010 - Assessing harms can be difficult. … Harms Assessments Harms Assessments Now, we will consider issues related to including observational … Assessing harms can be difficult. … Often the assessment of harms within RCTs is a secondary consideration, the quality and quantity of harms … Using Observational Studies To Assess Harms Using Observational Studies To Assess Harms Observational

36. AHRQ Slide Template 2009 (ppt file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/selecting-evidence.ppt
    January 01, 2010 - Assessing harms can be difficult. … Harms Assessments Harms Assessments Now, we will consider issues related to including observational … Assessing harms can be difficult. … Often the assessment of harms within RCTs is a secondary consideration, the quality and quantity of harms … Using Observational Studies To Assess Harms Using Observational Studies To Assess Harms Observational

37. Communicating Harms and Benefits of Prescription Drugs to Health Care Consumers | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/eccs-2006/white-paper
    November 01, 2017 - FAQs Home Evidence Reports Communicating Harms … SHARE: Communicating Harms … Communicating the uncertainty of harms and benefits of medical interventions. … Communicating Harms and Benefits of Prescription Drugs to Healthcare Consumers (PPT, 153 kb) What … MB) Marketing "Evidence" to Healthcare Consumers: Applying Social Marketing to Evidence About the Harms

38. Deprescribing To Reduce Medication Harms in Older Adults | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/deprescribing-mhs4/rapid-research
    February 01, 2024 - Home Evidence Reports Deprescribing To Reduce Medication Harms … SHARE: Deprescribing To Reduce Medication Harms … Making Healthcare Safer IV: Deprescribing To Reduce Medication Harms in Older Adults. … Project Timeline Making Healthcare Safer IV: Deprescribing to Reduce Medication Harms in Older Adults … of Service Rapid Evidence Product | Sep 14, 2023 Making Healthcare Safer IV: Potential Harms

39. Opioid Treatments for Chronic Pain | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/opioids-chronic-pain/research
    June 01, 2022 - Purpose of Review To assess the effectiveness and harms of opioid therapy for chronic … evidence on long-term effectiveness is very limited, and there is evidence of increased risk of serious harms … Evidence on the effectiveness and harms of alternative opioid dosing strategies and the effects of risk … to select studies of patients with chronic pain prescribed opioids that addressed effectiveness or harms … Evidence was insufficient to evaluate benefits and harms of opioid therapy in patients at higher risk

40. Comparative Effectiveness Review No. 258_Diagnostic Errors in the Emergency Department: A Systematic Review (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/diagnostic-error-executive-summary.pdf
    August 01, 2023 - , 2.6 million (2.0%) suffer an adverse event as a result, and about 370,000 (0.3%) suffer serious harms … each year this would be over 1,400 diagnostic errors, 500 diagnostic adverse events, and 75 serious harms … All three were conducted at university hospitals, and, for the two studies used to estimate harms, about … Malpractice claims associated with serious misdiagnosis-related harms involved failures of clinical … Together, they accounted for 68 percent (95% CI 66 to 71) of all serious harms from diagnostic error